ArticleOncotarget2015

Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer.

Urszula L McClurg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.